05.06.2014
- Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative...
15.05.2014
- AstraZeneca's chief executive Pascal Soriot said in an interview with the news agency Reuters he would engage with Pfizer if the price was right and the risks posed from forcing...
09.05.2014
- New legislation, expiring patents and increasing healthcare costs call for decisive changes in the global pharmaceutical industry. New markets for specialty medicines...
09.05.2014
- Staying in Control - IT security requires some effort. Not investing in security measures can turn out to be much more expensive than actually doing it, according to Marcel...
08.05.2014
- A Pharma Veteran's View - Dr. John L. LaMattina is the former Senior Vice President of Pfizer, and President, Pfizer Global Research and Development. In this role, Dr. LaMattina...
08.05.2014
- Changing Roles - China's far-reaching presence in the manufacture and supply of active pharmaceutical ingredients (APIs) around the world has long been known. However, with the...
28.03.2014
- Novasep, a leading supplier of manufacturing solutions to life science industries, today announces its unaudited consolidated results for the period ended December 31, 2013...
28.03.2014
- U.S. healthcare giant Baxter International has announced plans to split its pharmaceuticals and its medical devices businesses into two publicly traded companies from mid-2015...
24.03.2014
- After U.S. biotechnology stocks on Mar. 21 suffered their worst day since October 2011, investors raised questions as to whether the sector is finally running out of momentum. The...
18.03.2014
- A U.S. public interest group, Center for Food Safety (CFS), is asking a Washington, D.C. court to force the Department of Agriculture to turn over nearly 1,200 documents related to...
